SUPPA

SUPPA quantifies alternative splicing by computing Percentage Spliced In (PSI) values from RNA sequencing transcript quantifications to enable comparative analysis of splicing events.


Key Features:

  • Fast Quantification: Calculates Percentage Spliced In (PSI) values using fast transcript quantification methods from RNA-seq data.
  • Accuracy and Speed: Achieves accuracy comparable or superior to standard methods on simulated and real RNA-seq data while providing over 1000-fold speed improvements versus traditional approaches.
  • Annotation Sensitivity: Performance depends on annotation choice, with better splicing estimates obtained using complete transcript annotations rather than increasing transcript counts per gene.
  • De novo Reconstruction Compatibility: Can be coupled with de novo transcript reconstruction methods, although this coupling does not yield higher accuracies than known-transcript quantification.
  • Implementation: Implemented in Python 2.7.

Scientific Applications:

  • Splicing Analysis: Enables systematic, large-scale analysis of alternative splicing events across conditions using PSI metrics derived from RNA-seq.
  • Disease Research: Supports investigation of alternative splicing alterations relevant to diseases, particularly cancer.

Methodology:

SUPPA calculates relative inclusion values of alternative splicing events by exploiting fast transcript quantification; coupling with de novo transcript reconstruction methods has been shown not to improve accuracy over known-transcript quantification while remaining comparable to existing methodologies.

Topics

Details

License:
MIT
Maturity:
Mature
Cost:
Free of charge
Tool Type:
command-line tool
Operating Systems:
Linux, Windows, Mac
Programming Languages:
Python
Added:
4/14/2016
Last Updated:
11/25/2024

Operations

Publications

Alamancos GP, Pagès A, Trincado JL, Bellora N, Eyras E. Leveraging transcript quantification for fast computation of alternative splicing profiles. RNA. 2015;21(9):1521-1531. doi:10.1261/rna.051557.115. PMID:26179515. PMCID:PMC4536314.

PMID: 26179515
PMCID: PMC4536314
Funding: - Spanish Government: BIO2011-23920, CSD2009-00080 - Sandra Ibarra Foundation for Cancer: FSI-2013

Documentation